Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Circulating Tumor DNA Using Tagged Targeted Deep Sequencing to Assess Minimal Residual Disease in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.
Cirmena G, Garuti A, De Mariano M, Coco S, Ferrando L, Isnaldi E, Barbero V, Fregatti P, Del Mastro L, Ferrando F, Gonella R, Garlaschi A, Friedman D, Ballestrero A, Zoppoli G. Cirmena G, et al. Among authors: ballestrero a. J Oncol. 2020 Jan 22;2020:8132507. doi: 10.1155/2020/8132507. eCollection 2020. J Oncol. 2020. PMID: 32377196 Free PMC article.
Plasma Cell-Free DNA Integrity Assessed by Automated Electrophoresis Predicts the Achievement of Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer.
Cirmena G, Ferrando L, Ravera F, Garuti A, Dameri M, Gallo M, Barbero V, Ferrando F, Del Mastro L, Garlaschi A, Friedman D, Fregatti P, Ballestrero A, Zoppoli G. Cirmena G, et al. Among authors: ballestrero a. JCO Precis Oncol. 2022 Feb;6:e2100198. doi: 10.1200/PO.21.00198. JCO Precis Oncol. 2022. PMID: 35201850 Free PMC article.
Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases.
Zoppoli G, Garuti A, Cirmena G, di Cantogno LV, Botta C, Gallo M, Ferraioli D, Carminati E, Baccini P, Curto M, Fregatti P, Isnaldi E, Lia M, Murialdo R, Friedman D, Sapino A, Ballestrero A. Zoppoli G, et al. Among authors: ballestrero a. J Transl Med. 2017 May 1;15(1):91. doi: 10.1186/s12967-017-1195-7. J Transl Med. 2017. PMID: 28460632 Free PMC article.
Squalene epoxidase as a promising metabolic target in cancer treatment.
Cirmena G, Franceschelli P, Isnaldi E, Ferrando L, De Mariano M, Ballestrero A, Zoppoli G. Cirmena G, et al. Among authors: ballestrero a. Cancer Lett. 2018 Jul 1;425:13-20. doi: 10.1016/j.canlet.2018.03.034. Epub 2018 Mar 27. Cancer Lett. 2018. PMID: 29596888 Review.
Incidence and immunomic features of apyretic COVID-19 in patients affected by solid tumors: a prospective cohort study.
Ravera F, Borea R, Cirmena G, Dameri M, Ferrando L, Gallo M, Casini C, Fallani N, Stabile M, Barbero V, Murialdo R, Tixi L, Cappuccio M, Cuboni A, Sivieri I, Fornarini G, De Maria A, Ballestrero A, Zoppoli G. Ravera F, et al. Among authors: ballestrero a. J Transl Med. 2022 May 14;20(1):230. doi: 10.1186/s12967-022-03429-0. J Transl Med. 2022. PMID: 35568887 Free PMC article.
Sterol synthesis pathway inhibition as a target for cancer treatment.
Feltrin S, Ravera F, Traversone N, Ferrando L, Bedognetti D, Ballestrero A, Zoppoli G. Feltrin S, et al. Among authors: ballestrero a. Cancer Lett. 2020 Nov 28;493:19-30. doi: 10.1016/j.canlet.2020.07.010. Epub 2020 Jul 22. Cancer Lett. 2020. PMID: 32711099 Review.
211 results